Two Sigma Securities’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Two Sigma Securities's PACB Position: Q3 2026 in Review
Two Sigma Securities opened a new position in Pacific Biosciences (PACB) in Q3 2026: 314,693 shares worth $746K. The stake represents 0.06% of the portfolio and ranks #415 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in PACB as recently as Q2 2025.
Two Sigma Securities first reported a position in PACB in Q2 2019 and has held it in 7 quarters since. 204 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Two Sigma Securities held 314,693 shares of Pacific Biosciences worth $746K as of Q3 2026.
- Pacific Biosciences was a new Two Sigma Securities position in Q3 2026.
- Pacific Biosciences made up 0.06% of Two Sigma Securities's portfolio in Q3 2026, its #415 holding.
- Two Sigma Securities first reported a position in Pacific Biosciences in Q2 2019 and has held it in 7 quarters since.
- 204 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.